tiprankstipranks
Trending News
More News >
Robertet SA Cert.d'Invest. Em.87 (FR:CBE)
:CBE
France Market

Robertet SA Cert.d'Invest. Em.87 (CBE) AI Stock Analysis

Compare
1 Followers

Top Page

FR

Robertet SA Cert.d'Invest. Em.87

(CBE)

Rating:77Outperform
Price Target:
€851.00
▲(11.96%Upside)
Robertet SA's stock is supported by strong financial performance, characterized by solid revenue growth and efficient cost management. Technical indicators suggest moderate upward momentum, while the valuation appears fair. However, increasing debt levels and modest net profit margins are areas to watch. Overall, the company is well-positioned for sustainable growth, but careful monitoring of financial leverage is advised.

Robertet SA Cert.d'Invest. Em.87 (CBE) vs. iShares MSCI France ETF (EWQ)

Robertet SA Cert.d'Invest. Em.87 Business Overview & Revenue Model

Company DescriptionRobertet SA produces and sells perfumes, aromas, and natural products. The company operates in three segments: Raw materials, Fragrances, and Flavors. It also produces organic essential oils and active ingredients. The company operates in North America, Europe, the Asia Pacific, South America, Caribbean, Africa, and the Middle East. Robertet SA was founded in 1850 and is headquartered in Grasse, France.
How the Company Makes MoneyRobertet SA generates revenue primarily through the sale of its natural aromatic products and ingredients. The company's key revenue streams include the production and distribution of fragrances, flavors, and health & beauty products. By leveraging its extensive expertise in natural raw materials, Robertet caters to a diverse clientele across multiple industries, including food and beverage manufacturers, cosmetic companies, and personal care brands. The company also benefits from strategic partnerships and collaborations with other industry players, which enhance its product offerings and market reach. Additionally, Robertet's commitment to innovation and sustainability in sourcing and production processes contributes to its competitive advantage and financial performance.

Robertet SA Cert.d'Invest. Em.87 Financial Statement Overview

Summary
Overall, Robertet SA exhibits strong financial health with robust revenue growth, efficient cost management, and solid cash flow generation. The balance sheet is well-capitalized, though the increase in debt levels warrants careful monitoring. With continued focus on improving net margins and managing leverage, the company is well-positioned for sustainable growth.
Income Statement
85
Very Positive
Robertet SA has demonstrated a healthy growth in total revenue, with a significant increase from €721 million in 2023 to €808 million in 2024, marking a revenue growth rate of approximately 12%. The gross profit margin is strong, reflecting efficient production and cost management. EBIT and EBITDA margins are solid, indicating robust operational efficiency. However, the net profit margin could be improved, suggesting potential areas for cost optimization.
Balance Sheet
78
Positive
The company maintains a healthy equity ratio, highlighting strong capitalization with stockholders' equity making up 55% of total assets. The debt-to-equity ratio is moderate, indicating manageable leverage levels. However, there has been an increase in total debt from 2023 to 2024, which could pose risks if not carefully managed. Return on equity remains satisfactory, reflecting effective utilization of shareholder funds.
Cash Flow
80
Positive
Operating cash flow has increased from €102 million in 2023 to €112 million in 2024, demonstrating strong cash-generating capability. The free cash flow is positive and stable, though there was a slight decline from the previous year. This suggests effective capital expenditure management, although further improvements could enhance cash flow consistency.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
807.61M721.13M703.04M606.09M538.32M
Gross Profit
455.19M391.79M108.44M101.89M82.08M
EBIT
125.26M111.44M101.91M93.59M71.00M
EBITDA
160.03M132.89M125.61M110.99M92.14M
Net Income Common Stockholders
90.07M74.60M76.02M71.71M50.58M
Balance SheetCash, Cash Equivalents and Short-Term Investments
193.47M172.59M128.06M190.01M150.85M
Total Assets
1.01B927.13M847.21M783.29M669.71M
Total Debt
268.00M325.63M297.87M112.73M87.27M
Net Debt
109.86M182.87M169.83M-77.27M-63.54M
Total Liabilities
456.07M460.72M431.43M237.39M193.41M
Stockholders Equity
551.80M465.51M414.99M545.73M476.26M
Cash FlowFree Cash Flow
73.82M84.47M24.11M64.34M86.24M
Operating Cash Flow
112.41M101.82M46.87M85.12M101.07M
Investing Cash Flow
-38.33M-81.21M-67.36M-45.83M-22.97M
Financing Cash Flow
-58.93M-2.30M-43.28M-4.69M-22.03M

Robertet SA Cert.d'Invest. Em.87 Technical Analysis

Technical Analysis Sentiment
Positive
Last Price760.10
Price Trends
50DMA
743.43
Positive
100DMA
744.04
Positive
200DMA
763.97
Positive
Market Momentum
MACD
7.98
Positive
RSI
60.02
Neutral
STOCH
33.60
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:CBE, the sentiment is Positive. The current price of 760.1 is below the 20-day moving average (MA) of 764.12, above the 50-day MA of 743.43, and below the 200-day MA of 763.97, indicating a bullish trend. The MACD of 7.98 indicates Positive momentum. The RSI at 60.02 is Neutral, neither overbought nor oversold. The STOCH value of 33.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:CBE.

Robertet SA Cert.d'Invest. Em.87 Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
FRCBE
77
Outperform
€1.70B17.65
1.12%11.99%20.45%
51
Neutral
$2.04B-1.15-21.24%3.95%2.91%-30.44%
€4.81B15.014.87%5.74%
€2.53B49.79-2.97%4.84%
€1.70B20.2317.71%0.97%
$150.93M-15.38%
DE3BK
€82.93M20.548.65%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:CBE
Robertet SA Cert.d'Invest. Em.87
785.00
13.96
1.81%
GB:0IB0
Arkema
62.25
-19.48
-23.83%
GB:0NPX
IMERYS SA
29.86
-6.29
-17.40%
GB:0NZN
Robertet
872.00
50.55
6.15%
COOSF
Carbios SA
8.92
-15.08
-62.83%
DE:3BK
Baikowski SA
22.00
9.40
74.60%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.